GenMark Diagnostics Inc (GNMK)-医療機器分野:企業M&A・提携分析

◆英語タイトル:GenMark Diagnostics Inc (GNMK) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011699
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GenMark Diagnostics Inc (GenMark) is a medical device company that offers clinical testing systems. The company’s products comprise XT-8 systems and ePlex systems. Its pipeline products include eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test and others. GenMark develops products used in treatment of CNS infections, GI infections, genetic conditions, hepatitis, respiratory infections and sepsis. The company offers educational resources to medical professionals in the areas of cystic fibrosis, respiratory viral panel, thrombophilia and warfarin sensitivity. It operates in the US and Switzerland. GenMark is headquartered in Carlsbad, California, the US.

GenMark Diagnostics Inc (GNMK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GenMark Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GenMark Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
GenMark Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GenMark Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
GenMark Diagnostics Inc, Medical Equipment, Deal Details 10
Partnerships 10
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 10
GenMark Diagnostics Enters Into Co-Development Agreement With Advanced Liquid Logic For Integrated Diagnostic Platform 11
Equity Offering 12
GenMark Diagnostics Prices Public Offering of Shares for USD75 Million 12
GenMark Diagnostics Completes Public Offering Of Shares For US$86.3 Million 14
GenMark Diagnostics Completes Public Offering Of Shares For US$48 Million 16
GenMark Diagnostics Completes Public Offering Of Common Stock For US$35 Million 18
GenMark Diagnostics Inc – Key Competitors 20
GenMark Diagnostics Inc – Key Employees 21
GenMark Diagnostics Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Nov 02, 2017: GenMark Diagnostics Reports Third Quarter 2017 Results 23
Aug 01, 2017: GenMark Reports Second Quarter 2017 Results 24
May 02, 2017: GenMark Diagnostics Reports First Quarter 2017 Results 25
Feb 28, 2017: GenMark Diagnostics Reports Fourth Quarter and Full Year 2016 Results 26
Jan 10, 2017: GenMark Announces Preliminary Q4 2016 Financial Results 27
Nov 03, 2016: GenMark Diagnostics Reports Q3 Financial Results 28
Jul 28, 2016: GenMark Diagnostics Reports Q2 Financial Results 29
May 03, 2016: GenMark Reports First Quarter 2016 Results 30
Feb 23, 2016: GenMark Reports Fourth Quarter and Full Year 2015 Results 31
Jan 12, 2016: GenMark Announces Preliminary Q4 Financial Results and Initiation of ePlex Analytical Studies 32
Legal and Regulatory 33
Jun 29, 2017: GenMark Achieves CE Mark for its ePlex Blood Culture Identification Gram-Positive and Gram-Negative Panels 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
GenMark Diagnostics Inc, Medical Equipment, Key Facts, 2016 2
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
GenMark Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
GenMark Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
GenMark Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
GenMark Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
GenMark Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
PerkinElmer Enters Into Licensing Agreement With GenMark Diagnostics For Microfluidics Patent Portfolio 10
GenMark Diagnostics Enters Into Co-Development Agreement With Advanced Liquid Logic For Integrated Diagnostic Platform 11
GenMark Diagnostics Prices Public Offering of Shares for USD75 Million 12
GenMark Diagnostics Completes Public Offering Of Shares For US$86.3 Million 14
GenMark Diagnostics Completes Public Offering Of Shares For US$48 Million 16
GenMark Diagnostics Completes Public Offering Of Common Stock For US$35 Million 18
GenMark Diagnostics Inc, Key Competitors 20
GenMark Diagnostics Inc, Key Employees 21

★海外企業調査レポート[GenMark Diagnostics Inc (GNMK)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Portigon Ag:企業の戦略・SWOT・財務分析
    Portigon Ag - Strategy, SWOT and Corporate Finance Report Summary Portigon Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hyundai Engineering & Construction Co Ltd (000720):企業の財務・戦略的SWOT分析
    Hyundai Engineering & Construction Co Ltd (000720) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • genedrive plc (GDR)-製薬・医療分野:企業M&A・提携分析
    Summary genedrive plc (genedrive), formerly Epistem Holdings plc is a molecular diagnostics company. The company focuses on the development and commercialization of simple to use “point of need” system or point of care diagnostics platform for the diagnosis of infectious diseases and use in patient …
  • Health Dialog Services Corp:企業の戦略的SWOT分析
    Health Dialog Services Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Asiana Airlines Inc.:企業の戦略・SWOT・財務情報
    Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report Summary Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • RedHill Biopharma Ltd (RDHL):製薬・医療:M&Aディール及び事業提携情報
    Summary RedHill Biopharma Ltd (RedHill) is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology (GI) and cancer. The company’s commercial product portfolio consists of Donnatal for IBS and acute enterocolitis; Esomeprazole Strontium Delayed-Relea …
  • Luxfer Holdings PLC (LXFR):企業の財務・戦略的SWOT分析
    Luxfer Holdings PLC (LXFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • ASB Bank Limited:企業の戦略・SWOT・財務情報
    ASB Bank Limited - Strategy, SWOT and Corporate Finance Report Summary ASB Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Dabur India Ltd (DABUR):企業の財務・戦略的SWOT分析
    Dabur India Ltd (DABUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Charles River Laboratories International Inc (CRL):企業の財務・戦略的SWOT分析
    Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Monsanto Company:企業の戦略・SWOT・財務情報
    Monsanto Company - Strategy, SWOT and Corporate Finance Report Summary Monsanto Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • The Cumberland Insurance Group:企業の戦略・SWOT・財務情報
    The Cumberland Insurance Group - Strategy, SWOT and Corporate Finance Report Summary The Cumberland Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Telefonica UK Limited:企業の戦略的SWOT分析
    Telefonica UK Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Saudi Arabian Mining Co:企業の戦略・SWOT・財務情報
    Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report Summary Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sime Darby Berhad:企業の戦略・SWOT・財務情報
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nucor Corporation:企業のM&A・事業提携・投資動向
    Nucor Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nucor Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Compass Health Brands Corp:医療機器:M&Aディール及び事業提携情報
    Summary Compass Health Brands Corp (Compass Health) is a holding company. The company, through its subsidiaries, manufactures and markets medical equipment and devices. It offers bath safety, personal care, durable medical equipment, support surfaces, pressure prevention, mobility, pain management, …
  • Nuvo Pharmaceuticals Inc (NRI):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuvo Pharmaceuticals Inc (Nuvo), formerly Nuvo Research Inc, is a healthcare company that offers portfolio of commercial products and pharmaceutical manufacturing capabilities. The company’s product portfolio includes pennsaid, heated lidocaine and tetracaine patches. Its products deliver dr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆